We are a clinical-stage biopharmaceutical company spun out of the strategic combination of Beckley Psytech and Atai Life Sciences in 2025, advancing lead asset ELE-101. We develop patient-centered psychedelic treatments designed to fit the psychiatric care model and address unmet need in mental heal... Read more
Employees
1-10This company has no org chart yet
This company has no teams yet
This company has no offices yet